Laird Norton Wetherby Trust Company, LLC

Bank

Position in ANIX — Anixa Biosciences Inc

CIK 723204 Seattle, WA

Position in ANIX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,620,435

+$159,312 QoQ

Shares Held

578,727

+2.2% QoQ

Ownership

1.70%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

of 61 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Laird Norton Wetherby Trust Company, LLC holds $18,816,907 across 20 Biotechnology names. ANIX ranks #3 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,528	$5,726,302
2	ARGX	Argenx SE	2,282	$2,117,170
3	ANIX	Anixa Biosciences Inc This page	578,727	$1,620,435
4	REGN	Regeneron Pharmaceuticals, Inc.	2,419	$1,508,342
5	RPRX	Royalty Pharma plc	19,424	$1,089,102
6	ALNY	Alnylam Pharmaceuticals, Inc.	3,300	$993,398
7	INCY	Incyte Corp	7,051	$799,300
8	RVMD	Revolution Medicines, Inc.	4,060	$760,356

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,620,435	578,727	+2.2%	Shares	Sole	2026-08-14
2026-03-31	$1,461,123	566,327	-3.7%	Shares	Sole	2026-05-15
2025-12-31	$1,834,644	588,027	-1.5%	Shares	Sole	2026-02-17
2025-09-30	$1,970,875	597,235	-3.2%	Shares	Sole	2025-11-14
2025-06-30	$2,036,875	617,235	-0.8%	Shares	Sole	2025-08-14
2025-03-31	$1,779,592	622,235	0.0%	Shares	Sole	2025-05-15
2024-12-31	$1,443,585	622,235	+0.2%	Shares	Sole	2025-02-14
2024-09-30	$1,955,315	620,735	+2.7%	Shares	Sole	2024-11-14
2024-06-30	$1,335,359	604,235	0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,885,213	604,235	+63.8%	Shares	Sole	2024-05-15
2023-12-31	$1,431,079	368,835	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.